These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 26906743)

  • 1. The first decade of estrogen receptor cistromics in breast cancer.
    Flach KD; Zwart W
    J Endocrinol; 2016 May; 229(2):R43-56. PubMed ID: 26906743
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative Cistromics Reveals Genomic Cross-talk between FOXA1 and ERα in Tamoxifen-Associated Endometrial Carcinomas.
    Droog M; Nevedomskaya E; Kim Y; Severson T; Flach KD; Opdam M; Schuurman K; Gradowska P; Hauptmann M; Dackus G; Hollema H; Mourits M; Nederlof P; van Boven H; Linn SC; Wessels L; van Leeuwen FE; Zwart W
    Cancer Res; 2016 Jul; 76(13):3773-84. PubMed ID: 27197147
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Novel estrogen receptor-alpha binding sites and estradiol target genes identified by chromatin immunoprecipitation cloning in breast cancer.
    Lin Z; Reierstad S; Huang CC; Bulun SE
    Cancer Res; 2007 May; 67(10):5017-24. PubMed ID: 17510434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inference of hierarchical regulatory network of estrogen-dependent breast cancer through ChIP-based data.
    Gu F; Hsu HK; Hsu PY; Wu J; Ma Y; Parvin J; Huang TH; Jin VX
    BMC Syst Biol; 2010 Dec; 4():170. PubMed ID: 21167036
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
    Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
    Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genome-wide identification of direct target genes implicates estrogen-related receptor alpha as a determinant of breast cancer heterogeneity.
    Deblois G; Hall JA; Perry MC; Laganière J; Ghahremani M; Park M; Hallett M; Giguère V
    Cancer Res; 2009 Aug; 69(15):6149-57. PubMed ID: 19622763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Systematic identification of Ctr9 regulome in ERα-positive breast cancer.
    Zeng H; Lu L; Chan NT; Horswill M; Ahlquist P; Zhong X; Xu W
    BMC Genomics; 2016 Nov; 17(1):902. PubMed ID: 27829357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The genomic landscape of estrogen receptor α binding sites in mouse mammary gland.
    Palaniappan M; Nguyen L; Grimm SL; Xi Y; Xia Z; Li W; Coarfa C
    PLoS One; 2019; 14(8):e0220311. PubMed ID: 31408468
    [TBL] [Abstract][Full Text] [Related]  

  • 9. AKT alters genome-wide estrogen receptor alpha binding and impacts estrogen signaling in breast cancer.
    Bhat-Nakshatri P; Wang G; Appaiah H; Luktuke N; Carroll JS; Geistlinger TR; Brown M; Badve S; Liu Y; Nakshatri H
    Mol Cell Biol; 2008 Dec; 28(24):7487-503. PubMed ID: 18838536
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Functional genomics identifies a mechanism for estrogen activation of the retinoic acid receptor alpha1 gene in breast cancer cells.
    Laganière J; Deblois G; Giguère V
    Mol Endocrinol; 2005 Jun; 19(6):1584-92. PubMed ID: 15831516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endocrine therapy resistance can be associated with high estrogen receptor alpha (ERalpha) expression and reduced ERalpha phosphorylation in breast cancer models.
    Kuske B; Naughton C; Moore K; Macleod KG; Miller WR; Clarke R; Langdon SP; Cameron DA
    Endocr Relat Cancer; 2006 Dec; 13(4):1121-33. PubMed ID: 17158758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Research resource: whole-genome estrogen receptor α binding in mouse uterine tissue revealed by ChIP-seq.
    Hewitt SC; Li L; Grimm SA; Chen Y; Liu L; Li Y; Bushel PR; Fargo D; Korach KS
    Mol Endocrinol; 2012 May; 26(5):887-98. PubMed ID: 22446102
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RBCK1 drives breast cancer cell proliferation by promoting transcription of estrogen receptor alpha and cyclin B1.
    Gustafsson N; Zhao C; Gustafsson JA; Dahlman-Wright K
    Cancer Res; 2010 Feb; 70(3):1265-74. PubMed ID: 20103625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Unique ERalpha cistromes control cell type-specific gene regulation.
    Krum SA; Miranda-Carboni GA; Lupien M; Eeckhoute J; Carroll JS; Brown M
    Mol Endocrinol; 2008 Nov; 22(11):2393-406. PubMed ID: 18818283
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estrogen receptor α dependent regulation of estrogen related receptor β and its role in cell cycle in breast cancer.
    Madhu Krishna B; Chaudhary S; Mishra DR; Naik SK; Suklabaidya S; Adhya AK; Mishra SK
    BMC Cancer; 2018 May; 18(1):607. PubMed ID: 29843638
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Association of FGFR1 with ERα Maintains Ligand-Independent ER Transcription and Mediates Resistance to Estrogen Deprivation in ER
    Formisano L; Stauffer KM; Young CD; Bhola NE; Guerrero-Zotano AL; Jansen VM; Estrada MM; Hutchinson KE; Giltnane JM; Schwarz LJ; Lu Y; Balko JM; Deas O; Cairo S; Judde JG; Mayer IA; Sanders M; Dugger TC; Bianco R; Stricker T; Arteaga CL
    Clin Cancer Res; 2017 Oct; 23(20):6138-6150. PubMed ID: 28751448
    [No Abstract]   [Full Text] [Related]  

  • 17. Hierarchical modularity in ERα transcriptional network is associated with distinct functions and implicates clinical outcomes.
    Tang B; Hsu HK; Hsu PY; Bonneville R; Chen SS; Huang TH; Jin VX
    Sci Rep; 2012; 2():875. PubMed ID: 23166858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. CUEDC1 is a primary target of ERα essential for the growth of breast cancer cells.
    Lopes R; Korkmaz G; Revilla SA; van Vliet R; Nagel R; Custers L; Kim Y; van Breugel PC; Zwart W; Moumbeini B; Manber Z; Elkon R; Agami R
    Cancer Lett; 2018 Nov; 436():87-95. PubMed ID: 30145202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. An H3K4me3 reader, BAP18 as an adaptor of COMPASS-like core subunits co-activates ERα action and associates with the sensitivity of antiestrogen in breast cancer.
    Sun G; Wang C; Wang S; Sun H; Zeng K; Zou R; Lin L; Liu W; Sun N; Song H; Liu W; Zhou T; Jin F; Shan Z; Zhao Y
    Nucleic Acids Res; 2020 Nov; 48(19):10768-10784. PubMed ID: 32986841
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From the Cover: Location analysis of estrogen receptor alpha target promoters reveals that FOXA1 defines a domain of the estrogen response.
    Laganière J; Deblois G; Lefebvre C; Bataille AR; Robert F; Giguère V
    Proc Natl Acad Sci U S A; 2005 Aug; 102(33):11651-6. PubMed ID: 16087863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.